Volume 29, Number 1—January 2023
Dispatch
COVID-19 Symptoms by Variant Period in the North Carolina COVID-19 Community Research Partnership, North Carolina, USA
Table 2
Variant period | Beta (95% CI)† | p value | Marginal mean duration, d (95% CI)‡ |
|
---|---|---|---|---|
Pre-Delta | NA | NA | 9.7 (9.0–10.4) | |
Delta | −1.3 (−2.0 to −0.57) | <0.001 | 8.4 (7.8–9.1) | |
Omicron | −3.8 (−4.6 to −3.1) | <0.001 | 5.9 (5.3–6.4) |
*Data are adjusted for age, vaccination status, boosting, reinfection, and sex. NA, not applicable. †Differences from reference wave (pre-Delta) in the linear model. ‡Marginal mean represents the estimated mean duration of a symptomatic period across all levels of age, vaccination status, boosting, reinfection, and sex.
1These senior authors contributed equally to this article.
Page created: December 09, 2022
Page updated: December 22, 2022
Page reviewed: December 22, 2022
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.